KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Long-Term Deferred Tax (2019 - 2025)

Historic Long-Term Deferred Tax for GoodRx Holdings (GDRX) over the last 6 years, with Q3 2025 value amounting to $69.1 million.

  • GoodRx Holdings' Long-Term Deferred Tax rose 482.93% to $69.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 million, marking a year-over-year increase of 482.93%. This contributed to the annual value of $77.2 million for FY2024, which is 1825.4% up from last year.
  • GoodRx Holdings' Long-Term Deferred Tax amounted to $69.1 million in Q3 2025, which was up 482.93% from $77.2 million recorded in Q2 2025.
  • Over the past 5 years, GoodRx Holdings' Long-Term Deferred Tax peaked at $77.2 million during Q4 2024, and registered a low of $13.0 million during Q2 2021.
  • Over the past 4 years, GoodRx Holdings' median Long-Term Deferred Tax value was $65.3 million (recorded in 2023), while the average stood at $58.1 million.
  • As far as peak fluctuations go, GoodRx Holdings' Long-Term Deferred Tax surged by 261630.11% in 2021, and later soared by 411.89% in 2024.
  • Over the past 4 years, GoodRx Holdings' Long-Term Deferred Tax (Quarter) stood at $45.8 million in 2021, then skyrocketed by 42.43% to $65.3 million in 2023, then increased by 18.25% to $77.2 million in 2024, then dropped by 10.48% to $69.1 million in 2025.
  • Its last three reported values are $69.1 million in Q3 2025, $77.2 million for Q2 2025, and $77.2 million during Q1 2025.